Skip to content
Screener

Artivion AORT Contingent consideration fair value adjustments

Contingent consideration fair value adjustments at other companies

Boston Scientific logo
Boston ScientificBSX
-$30M-700%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$868K+214%
TFX
TeleflexTFX
-$67K-100%
CryoPort, Inc. logo
CryoPort, Inc.CYRX
$33K+243%
Merit Medical Systems logo
Merit Medical SystemsMMSI

Other financials

Income statement

See full
Revenue$125.8M+11.3%
Gross profit$80.5M+10.1%
Operating income-$8.4M-200%
Net income-$13.5M-1,104%
EPS (diluted)-$0.28-1,033%

Balance sheet

See full
Cash & equivalents$77.3M+44.6%
Total debt$408.0M+54.7%
Total equity$445.6M+6.1%
Total assets$1.1B+27.9%

Cash flow

See full
Operating cash flow-$1.3M-108%
CapEx$10.7M+227%
Free cash flow-$12.0M

Valuation

See full
Market cap$1.28B-33.5%
Enterprise value$1.61B-24.6%
P/S2.7×-2.0×

Profitability

See full
Gross margin64.4%+0.4pp
Operating margin4.4%0.0pp
Net margin-0.7%-0.3pp
FCF margin-0.1%-2.5pp

Returns & leverage

See full
Return on equity-0.7%-0.3pp
Debt / equity0.9×+0.3×
Current ratio3.5×-1.3×

Where this comes from

Reported directly by Artivion in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.

The source filing: Artivion’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 1:57 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054746
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Non-cash lease expense2,6122,510
Write-down of inventories and deferred preservation costs2,3682,379
Deferred income taxes(1,421)(231)
Change in fair value of contingent consideration9,710(210)
Losses on inducement/extinguishment of debt2,664
Other(2,590)(7,423)
Changes in operating assets and liabilities, net of acquisition:
Receivables(7,971)(9,660)

Item 1. Financial Statements.

FAQ

What is Artivion's contingent consideration fair value adjustments?
Artivion (AORT) reported contingent consideration fair value adjustments of $7.97M in Q2 2026.
How has Artivion's contingent consideration fair value adjustments changed year-over-year?
Artivion's contingent consideration fair value adjustments increased by 204.2% year-over-year, from $2.62M to $7.97M.
What is the long-term trend for Artivion's contingent consideration fair value adjustments?
Over 3 years (2021 to 2025), Artivion's contingent consideration fair value adjustments has grown at a -4.6% compound annual growth rate (CAGR), from $8.87M to $7.7M.
What does contingent consideration fair value adjustments mean?
Contingent consideration fair value adjustments

Ask your AI about Artivion's contingent consideration fair value adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude